Crossref journal-article
American Society of Hematology
Blood (234)
Bibliography

Colman, R. W., & Schmaier, A. H. (1997). Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes. Blood, 90(10), 3819–3843.

Authors 2
  1. Robert W. Colman (first)
  2. Alvin H. Schmaier (additional)
References 296 Referenced 467
  1. 10.1152/ajplegacy.1949.156.2.261 / Am J Physiol / Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. by Roche e Silva (1949)
  2. 10.1172/JCI108247 / J Clin Invest / Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. by Colman (1975)
  3. 10.1172/JCI108248 / J Clin Invest / Flaujeac trait. Deficiency of human plasma kininogen. by Wuepper (1975)
  4. 10.1172/JCI108009 / J Clin Invest / Fitzgerald trait: Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/DIL). by Saito (1975)
  5. 10.1016/S0021-9258(17)39515-7 / J Biol Chem / Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. Primary structures of two human prekininogens. by Takagaki (1985)
  6. 10.1016/S0021-9258(17)39516-9 / J Biol Chem / Structural organization of the human kininogen gene and a model for its evolution. by Kitamura (1985)
  7. 10.1007/BF00204179 / Hum Genet / The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction. by Fong (1991)
  8. 10.1159/000133192 / Cytogenet Cell Genet / Chromosomal mapping of human kininogen gene (KNG) to 3q26→qter. by Cheung (1992)
  9. 10.1159/000133984 / Cytogenet Cell Genet / Three members of the human cystatin gene superfamily, AHSG, HRG, and KNG, map within one megabase of genomic DNA at 3q27. by Rizzu (1995)
  10. 10.1016/S0021-9258(19)38785-X / J Biol Chem / A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen genes. by Kakizuka (1990)
  11. 10.1016/S0021-9258(19)49471-4 / J Biol Chem / Genetic basis of total kininogen deficiency in Williams' trait. by Cheung (1993)
  12. 10.1016/S0021-9258(19)85325-5 / J Biol Chem / A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats. by Hayashi (1993)
  13. 10.1016/0167-4781(92)90069-C / Biochim Biophys Acta / Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. by Chen (1992)
  14. {'key': '2019111912390634900_B14', 'first-page': '112', 'article-title': 'Immunoblotting of plasma in a pregnant patient with hereditary angioedema.', 'volume': '115', 'author': 'Chhibber', 'year': '1990', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Immunoblotting of plasma in a pregnant patient with hereditary angioedema. by Chhibber (1990)
  15. 10.1016/0167-4889(94)00218-4 / Biochim Biophys Acta / Murine fibroblasts synthesize and secrete kininogen in response to cyclic-AMP, prostaglandin E2 and tumor necrosis factor. by Takano (1995)
  16. {'key': '2019111912390634900_B16', 'first-page': '77', 'article-title': 'Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody.', 'volume': '119', 'author': 'Scott', 'year': '1992', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody. by Scott (1992)
  17. {'key': '2019111912390634900_B17', 'first-page': '25', 'article-title': 'Some data on two purified kininogens from human plasma.', 'volume': '29', 'author': 'Jacobsen', 'year': '1967', 'journal-title': 'Br J Pharmacol'} / Br J Pharmacol / Some data on two purified kininogens from human plasma. by Jacobsen (1967)
  18. 10.1172/JCI112472 / J Clin Invest / High molecular weight kininogen is an inhibitor of platelet calpain. by Schmaier (1986)
  19. 10.1172/JCI110901 / J Clin Invest / High-molecular weight kininogen. A secreted platelet protein. by Schmaier (1983)
  20. 10.1016/S0021-9258(18)37596-3 / J Biol Chem / The expression of high molecular weight kininogen on human umbilical vein endothelial cells. by Schmaier (1988)
  21. 10.1172/JCI114151 / J Clin Invest / Human neutrophils contain and bind high molecular weight kininogen. by Gustafson (1989)
  22. 10.1016/S0021-9258(19)68671-0 / J Biol Chem / Characterization and localization of human renal kininogen. by Proud (1981)
  23. 10.1515/bchm3.1987.368.2.1151 / Biol Chem Hoppe Seyler / Quantification of kininogen in human renal medulla. by Hallbach (1987)
  24. 10.1016/0167-4838(87)90178-6 / Biochim Biophys Acta / Interstitial-tissue localization of high-molecular-weight kininogen in guinea-pig skin. by Yamamoto (1987)
  25. 10.1021/bi00319a005 / Biochemistry / Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. by Ohkubo (1984)
  26. 10.1016/S0021-9258(17)36995-8 / J Biol Chem / The shape of high molecular weight kininogen: Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. by Weisel (1994)
  27. 10.1042/bj2340429 / Biochem J / Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. by Salvesen (1986)
  28. 10.1016/S0021-9258(19)75800-1 / J Biol Chem / Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. by Schmaier (1987)
  29. 10.1016/S0021-9258(18)37804-9 / J Biol Chem / Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions. by Vogel (1988)
  30. 10.1016/S0021-9258(19)74347-6 / J Biol Chem / Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain. by Bradford (1993)
  31. 10.1182/blood.V85.11.3134.bloodjournal85113134 / Blood / High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium. by Hasan (1995)
  32. 10.1055/s-0038-1649886 / Thromb Haemost / Conformational changes in low molecular weight kininogen alters its ability to bind to endothelial cells. by Hasan (1995)
  33. 10.1083/jcb.116.2.465 / J Cell Biol / Inhibition of cell adhesion by high molecular weight kininogen. by Asakura (1992)
  34. 10.1021/bi00396a025 / Biochemistry / Heavy chain of human high molecular weight and low molecular weight kininogen binds calcium ion. by Ishiguro (1987)
  35. 10.1182/blood.V81.11.2936.2936 / Blood / Bradykinin regulates the expression of kininogen binding sites on endothelial cells. by Zini (1993)
  36. 10.1172/JCI112567 / J Clin Invest / High molecular weight kininogen binds to unstimulated platelets. by Gustafson (1986)
  37. 10.1021/bi00361a022 / Biochemistry / Binding of coagulation factor XI to washed human platelets. by Greengard (1986)
  38. 10.1016/S0021-9258(18)68839-8 / J Biol Chem / The binding of high molecular weight kininogen to cultured human endothelial cells. by van Iwaarden (1988)
  39. {'key': '2019111912390634900_B39', 'first-page': '1162', 'article-title': 'Digestive process and regulation of renal excretory function. Pepsanurin and prokinins inhibitors of diuresis mediated by atrial natriuretic peptide.', 'volume': '122', 'author': 'Croxatto', 'year': '1995', 'journal-title': 'Rev Med Chile'} / Rev Med Chile / Digestive process and regulation of renal excretory function. Pepsanurin and prokinins inhibitors of diuresis mediated by atrial natriuretic peptide. by Croxatto (1995)
  40. 10.1042/bj2700083 / Biochem J / Kinetics of inhibition of platelet calpain II by human kininogens. by Bradford (1990)
  41. 10.1016/0014-5793(93)80628-8 / FEBS Lett / Cloning, expression and characterization of human kininogen domain 3. by Auerswald (1993)
  42. 10.1016/0014-5793(94)01380-J / FEBS Lett / Interaction of cysteine proteinases with recombinant kininogen domain 2, expressed in Escherichia coli. by Ylinenjarvi (1995)
  43. 10.1007/BF01908533 / J Protein Chem / Structural requirements for cathepsin B and cathepsin H inhibition by kininogens. by Bano (1996)
  44. 10.1016/S0021-9258(18)53048-9 / J Biol Chem / Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. by Scott (1993)
  45. 10.1182/blood.V67.1.119.bloodjournal671119 / Blood / High molecular weight kininogen: Localization in the unstimulated and activated platelet and activation by a platelet calpain(s). by Schmaier (1986)
  46. 10.1182/blood.V75.6.1273.1273 / Blood / Membrane expression of platelet calpain. by Schmaier (1990)
  47. 10.1016/S0021-9258(18)53191-4 / J Biol Chem / In situ capture of m-calpain activation of platelets. by Saido (1993)
  48. 10.1016/S0021-9258(20)89569-6 / J Biol Chem / Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. by Meloni (1991)
  49. 10.1182/blood.V81.5.1306.1306 / Blood / Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. by Reddigari (1993)
  50. 10.1016/S0021-9258(19)50583-X / J Biol Chem / Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. by Jiang (1992)
  51. 10.1016/S0021-9258(17)32168-3 / J Biol Chem / High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). by Wachtfogel (1994)
  52. 10.1002/j.1460-2075.1988.tb03109.x / EMBO J / The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. by Bode (1988)
  53. 10.1016/S0021-9258(18)92103-4 / J Biol Chem / Identification of an endothelial cell binding site on kininogen domain D3. by Herwald (1995)
  54. 10.1055/s-0038-1648823 / Thromb Haemost / Platelet thrombospondin interactions with human high and low molecular weight kininogens. by DeLa (1994)
  55. 10.1182/blood.V77.3.500.500 / Blood / High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. by Puri (1991)
  56. 10.1161/01.CIR.94.3.517 / Circulation / Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of α-thrombin-induced platelet activation. by Hasan (1996)
  57. 10.1074/jbc.271.19.11228 / J Biol Chem / Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 domain 3 in the heavy chain of high molecular weight kininogen. by Kunapuli (1996)
  58. 10.1093/oxfordjournals.jbchem.a133339 / J Biochem / Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. by Mori (1981)
  59. {'key': '2019111912390634900_B59', 'first-page': '182', 'article-title': 'Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.', 'volume': '112', 'author': 'Schmaier', 'year': '1988', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. by Schmaier (1988)
  60. 10.1016/S0021-9258(17)34010-3 / J Biol Chem / Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein. by Tayeh (1994)
  61. 10.1016/S0021-9258(18)32151-3 / J Biol Chem / Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. by Wiggins (1983)
  62. 10.1016/S0021-9258(19)85161-X / J Biol Chem / Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function. by Scott (1985)
  63. 10.1515/bchm3.1988.369.2.1009 / Biol Chem Hoppe Seyler / Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase. by Sato (1988)
  64. 10.1084/jem.167.6.1895 / J Exp Med / Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity. by Kleniewski (1988)
  65. 10.1016/S0021-9258(18)31769-1 / J Biol Chem / The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. by Hasan (1994)
  66. 10.1182/blood.V79.5.1233.1233 / Blood / High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. by Meloni (1992)
  67. 10.1074/jbc.270.33.19256 / J Biol Chem / Mapping the cell binding site on high molecular weight kininogen domain 5. by Hasan (1995)
  68. {'key': '2019111912390634900_B68'}
  69. 10.1016/S0021-9258(18)61470-X / J Biol Chem / Effects of chemical modifications on the surface- and protein-binding properties of the light chain of human high molecular weight kininogen. by Retzios (1987)
  70. 10.1016/S0021-9258(18)53802-3 / J Biol Chem / Deletion mutagenesis of high molecular weight kininogen light chain: Identification of two anionic surface binding subdomains. by Kunapuli (1993)
  71. 10.1021/bi00429a039 / Biochemistry / Binding of heparin to human high molecular weight kininogen. by Bjork (1989)
  72. 10.1002/pro.5560010115 / Protein Sci / The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. by DeLa (1992)
  73. 10.1042/bj3050173 / Biochem J / Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. by Ben (1995)
  74. 10.1172/JCI111319 / J Clin Invest / Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. by Scott (1984)
  75. 10.1016/S0021-9258(18)66724-9 / J Biol Chem / Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity. by Tait (1986)
  76. 10.1016/S0021-9258(18)60859-2 / J Biol Chem / Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. by Tait (1987)
  77. 10.1016/S0021-9258(19)38373-5 / J Biol Chem / Mapping of the prekallikrein binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries: Mimicking of the predicted binding site by anti-idiotypic antibodies. by Vogel (1990)
  78. 10.1016/S0021-9258(17)43773-2 / J Biol Chem / Protein-protein interactions in contact activation of blood coagulation. Characterization of fluorescein-labeled human high molecular weight kininogen-light chain as a probe. by Bock (1983)
  79. 10.1016/S0021-9258(17)38892-0 / J Biol Chem / Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains. by Bock (1985)
  80. 10.1007/BF01025019 / J Protein Chem / Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen. by Scarsdale (1990)
  81. 10.1007/BF01025629 / J Protein Chem / Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen. by You (1991)
  82. 10.1016/0196-9781(93)90061-K / Peptides / Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen. by You (1993)
  83. 10.1182/blood.V74.2.695.695 / Blood / Monoclonal antibody to human high molecular weight kininogen recognizes its prekallikrein binding site and inhibits coagulant activity. by Reddigari (1989)
  84. 10.1016/S0021-9258(18)52980-X / J Biol Chem / Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties. by Kaufmann (1993)
  85. 10.1055/s-0038-1649800 / Thromb Haemost / Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture. by Lenich (1995)
  86. {'key': '2019111912390634900_B86'}
  87. 10.1021/bi00220a027 / Biochemistry / Gene structure and chromosomal localization of plasma kallikrein. by Beaubien (1991)
  88. 10.1021/bi00397a004 / Biochemistry / Organization of the gene for human factor XI. by Asakai (1987)
  89. 10.1021/bi00357a017 / Biochemistry / Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. by Chung (1986)
  90. 10.1021/bi00222a007 / Biochemistry / Location of the disulfide bonds in human plasma prekallikrein: The presence of four novel apple domains in the amino-terminal portion of the molecule. by McMullen (1991)
  91. 10.1021/bi00222a008 / Biochemistry / Location of the disulfide bonds in human coagulation factor XI: The presence of a Tandem apple domain. by McMullen (1991)
  92. 10.1016/S0021-9258(17)40034-2 / J Biol Chem / Hageman factor substrates. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. by Mandle (1977)
  93. 10.1111/j.1432-1033.1979.tb02035.x / Eur J Biochem / Human plasma prekallikrein: A rapid high yield method for purification. by Scott (1979)
  94. 10.1182/blood.V59.5.963.bloodjournal595963 / Blood / Assay of prekallikrein in human plasma: Comparison of amidolytic, esterolytic, coagulation, and immunochemical assays. by Fisher (1982)
  95. 10.1111/j.1476-5381.1970.tb10591.x / Br J Pharmacol / The isolation of human plasma prekallikrein. by McConnell (1970)
  96. 10.1084/jem.135.1.1 / J Exp Med / Plasma prekallikrein: Isolation, characterization, and mechanism of action. by Wuepper (1972)
  97. 10.1016/S0021-9258(17)42473-2 / J Biol Chem / Human plasma prekallikrein: Immunoaffinity purification and activation to α- and β-kallikrein. by Burger (1986)
  98. 10.1182/blood.V65.2.311.bloodjournal652311 / Blood / Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties. by Colman (1985)
  99. 10.1073/pnas.73.11.4179 / Proc Natl Acad Sci USA / Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. by Mandle (1976)
  100. 10.1016/S0021-9258(18)92953-4 / J Biol Chem / Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371). by Page (1991)
  101. 10.1006/abbi.1994.1424 / Arch Biochem Biophys / Localization of the binding site on plasma kallikrein for high molecular weight kininogen to both apple 1 and apple 4 domains of the heavy chain. by Page (1994)
  102. {'key': '2019111912390634900_B102'}
  103. 10.1021/bi960547j / Biochemistry / Direct evidence for multi-facial contacts between high molecular weight kininogen and plasma prekallikrein. by Lin (1996)
  104. 10.1074/jbc.271.22.13061 / J Biol Chem / Mapping of the discontinuous kininogen binding site of prekallikrein. by Herwald (1996)
  105. 10.4049/jimmunol.104.3.574 / J Immunol / Interaction of plasma kallikrein with the C1 inhibitor. by Gigli (1970)
  106. 10.1172/JCI110743 / J Clin Invest / Inactivation of Kallikrein in plasma. by Van der Graff (1983)
  107. 10.1172/JCI110470 / J Clin Invest / Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. by Schapira (1982)
  108. 10.1021/bi00289a037 / Biochemistry / Interaction of human plasma, kallikrein and its light chain with C1 inhibitor. by Van der Graff (1983)
  109. 10.1021/bi00532a024 / Biochemistry / High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. by Schapira (1982)
  110. 10.1021/bi00513a006 / Biochemistry / Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. by Schapira (1981)
  111. {'key': '2019111912390634900_B111', 'first-page': '882', 'article-title': 'Plasma prekallikrein assay: Reversible inhibition of C1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.', 'volume': '104', 'author': 'Schmaier', 'year': '1984', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Plasma prekallikrein assay: Reversible inhibition of C1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species. by Schmaier (1984)
  112. 10.1016/0003-9861(76)90567-1 / Arch Biochem Biophys / Antithrombin-heparin cofactor: An inhibitor of plasma Kallikrein. by Lahiri (1976)
  113. 10.1021/bi00412a005 / Biochemistry / Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. by Meijers (1988)
  114. 10.1055/s-0038-1647452 / Thromb Haemost / Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma. by Espana (1991)
  115. 10.1182/blood.V73.4.994.994 / Blood / Plasminogen activators in dextran sulfate-activated euglobulin functions: A molecular analysis of factor XII and prekallikrein-dependent fibrinolysis. by Hauert (1989)
  116. 10.1016/S0021-9258(17)35674-0 / J Biol Chem / The activation of prourokinase by plasma kallikrein and its inactivation by thrombin. by Ichinose (1986)
  117. 10.1007/BF00273661 / Hum Genet / Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids. by Citarella (1988)
  118. 10.1007/BF01534407 / Somat Cell Mol Genet / Structural gene encosing human factor XII is located at 5q33-qter. by Rolye (1988)
  119. 10.1016/S0021-9258(19)76478-3 / J Biol Chem / Characterization of the human blood coagulation factor XII gene. by Cool (1987)
  120. 10.1016/S0021-9258(17)38776-8 / J Biol Chem / Characterization of human blood coagulation factor XII cDNA. by Cool (1985)
  121. 10.1021/bi00355a009 / Biochemistry / Characterization of a cDNA coding for human factor XII (Hageman factor). by Que (1986)
  122. 10.1016/S0076-6879(76)45009-7 / Methods Enzymol / Human factor XII (Hageman factor). by Griffin (1976)
  123. 10.1172/JCI107799 / J Clin Invest / Structural changes accompanying enzymatic activation of Hageman factor. by Revak (1974)
  124. {'key': '2019111912390634900_B124', 'first-page': '506', 'article-title': 'Radioimmunoassay of human Hageman factor (factor XII).', 'volume': '88', 'author': 'Saito', 'year': '1976', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Radioimmunoassay of human Hageman factor (factor XII). by Saito (1976)
  125. {'key': '2019111912390634900_B125', 'first-page': '463', 'article-title': 'Hepatocytes express blood coagulation factor XII (Hageman factor).', 'volume': '115', 'author': 'Gordon', 'year': '1990', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Hepatocytes express blood coagulation factor XII (Hageman factor). by Gordon (1990)
  126. {'key': '2019111912390634900_B126', 'first-page': '52', 'article-title': 'Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII.', 'volume': '111', 'author': 'Gordon', 'year': '1988', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. by Gordon (1988)
  127. 10.1055/s-0038-1645045 / Thromb Haemost / The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII. by Mitropoulos (1990)
  128. {'key': '2019111912390634900_B128', 'first-page': '353', 'article-title': 'Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen-and prolactin-treated rats.', 'volume': '117', 'author': 'Gordon', 'year': '1991', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen-and prolactin-treated rats. by Gordon (1991)
  129. 10.1210/endo.136.11.7588244 / Endocrinology / Molecular basis of estrogen regulation of Hageman factor XII gene expression. by Farsetti (1995)
  130. 10.1073/pnas.88.10.4382 / Proc Natl Acad Sci USA / Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. by Schmeidler-Sapiro (1991)
  131. 10.1073/pnas.93.5.2174 / Proc Natl Acad Sci USA / Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. by Gordon (1996)
  132. 10.1016/S0021-9258(18)61089-0 / J Biol Chem / A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation. by Pixley (1987)
  133. 10.1016/S0021-9258(18)60491-0 / J Biol Chem / Mapping of a putative surface-binding site of human coagulation factor XII. by Clarke (1989)
  134. 10.1111/j.1432-1033.1996.0240q.x / Eur J Biochem / Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces. by Citrella (1996)
  135. 10.1084/jem.138.6.1564 / J Exp Med / Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. by Cochrane (1973)
  136. 10.1016/S0021-9258(18)41830-3 / J Biol Chem / Human factor XII (Hageman factor) autoactivation by dextran sulfate: Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. by Samuel (1992)
  137. 10.1182/blood.V66.1.198.bloodjournal661198 / Blood / Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III. by Pixley (1985)
  138. 10.1073/pnas.86.21.8319 / Proc Natl Acad Sci USA / Coagulation factor XII (Hageman factor) Washington DC: Inactive factor XIIa results from Cys571 to Ser substitution. by Miyata (1989)
  139. 10.1182/blood.V78.4.997.997 / Blood / Functional characterization of an abnormal factor XII molecule (F XII Bern). by Wuillemin (1991)
  140. 10.1084/jem.138.6.1564 / J Exp Med / Activation of Hageman factor in solid and fluid phases: A critical role of kallikrein. by Cochrane (1973)
  141. 10.1172/JCI108741 / J Clin Invest / The binding and cleavage characteristics of huma Hageman factor during contact activation: a comparison of normal plasma with plasma deficient in factor XI, prekallikrein or high molecular weight kininogen. by Revak (1977)
  142. 10.1073/pnas.75.4.1998 / Proc Natl Acad Sci USA / The role of surface in the surface-dependent activation of Hageman factor (blood coagulation factor XII). by Griffin (1978)
  143. 10.1182/blood.V61.4.652.652 / Blood / The binding of bovine factor XII to kaolin. by Kirby (1983)
  144. 10.1084/jem.150.5.1122 / J Exp Med / The autoactivation of rabbit Hageman factor. by Wiggins (1979)
  145. 10.1016/0006-291X(80)90774-3 / Biochem Biophys Res Commun / Autoactivability of human Hageman factor. by Miller (1980)
  146. 10.1016/S0021-9258(20)79699-7 / J Biol Chem / Autoactivation of human Hageman factor: Demonstration utilizing a synthetic substrate. by Silverberg (1980)
  147. 10.1016/S0021-9258(19)68105-6 / J Biol Chem / The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. by Dunn (1982)
  148. {'key': '2019111912390634900_B148', 'first-page': '31', 'article-title': 'Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.', 'volume': '102', 'author': 'Espana', 'year': '1983', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. by Espana (1983)
  149. 10.1021/bi00297a016 / Biochemistry / Kinetics of activation and autoactivation of human factor XII. by Tankersley (1984)
  150. 10.1097/00001721-199310000-00002 / Blood Coagul Fibrinolysis / Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor). by Schousboe (1993)
  151. 10.1016/S0021-9258(18)31412-1 / J Biol Chem / Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement. by Bernardo (1993)
  152. 10.1016/S0021-9258(18)31413-3 / J Biol Chem / Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. by Bernardo (1993)
  153. 10.1111/j.1432-1033.1997.00491.x / Eur J Biochem / Identification of the Zn2+ binding sites in factor XII and its activation derivatives. by Rojkjaer (1997)
  154. 10.1172/JCI109651 / J Clin Invest / Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. by Wiggins (1980)
  155. 10.1016/S0021-9258(19)43251-1 / J Biol Chem / Isolation of the high molecular weight activators of prekallikrein. by Bagdasarian (1973)
  156. 10.4049/jimmunol.105.4.802 / J Immunol / A prealbumin activator of prekallikrein. by Kaplan (1970)
  157. 10.4049/jimmunol.105.5.1307 / J Immunol / Plasma Kinin system: Proenzyme components. by Wuepper (1970)
  158. 10.1016/0002-9343(79)90253-5 / Am J Med / Molecular assembly in the contact phase of the Hageman factor system. by Cochrane (1979)
  159. 10.1084/jem.133.4.696 / J Exp Med / A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. by Kaplan (1971)
  160. 10.1084/jem.147.3.719 / J Exp Med / Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. by Revak (1978)
  161. 10.1172/JCI108361 / J Clin Invest / The relationship of structure and function in human Hageman factor. The association of enzymatic binding activities with separate regions of the molecule. by Revak (1976)
  162. {'key': '2019111912390634900_B162', 'first-page': '809', 'article-title': 'Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified C1-inactivator.', 'volume': '76', 'author': 'Forbes', 'year': '1970', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified C1-inactivator. by Forbes (1970)
  163. 10.1172/JCI107313 / J Clin Invest / Inhibition by C1-INH of Hageman factor fragment activation of coagulation, fibrinolysis and kinin-generation. by Schreiber (1973)
  164. 10.1172/JCI111360 / J Clin Invest / Inactivation of factor XII active fragment in normal plasma: Predominant role of C1-inhibitor. by de Agostini (1984)
  165. 10.1016/S0021-9258(18)89653-3 / J Biol Chem / The regulation of human factor XIIa by plasma proteinase inhibitors. by Pixley (1985)
  166. 10.1016/0003-9861(87)90606-0 / Arch Biochem Biophys / Effect of negatively charged activating compounds on inactivation of factor XIIa by C1 inhibitor. by Pixley (1987)
  167. 10.1016/S0021-9258(17)32973-3 / J Biol Chem / The inhibition of human activated Hageman factor (HF ) by human antithrombin-heparin cofactor (AT). by Stead (1976)
  168. 10.1182/blood.V66.1.198.bloodjournal661198 / Blood / Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III. by Pixley (1985)
  169. 10.1016/S0021-9258(18)80127-2 / J Biol Chem / Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. by Berrettini (1989)
  170. 10.1073/pnas.90.1.198 / Proc Natl Acad Sci USA / Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor. by Kleniewski (1993)
  171. 10.1021/bi00321a090 / Biochemistry / Receptors for high molecular weight kininogen on stimulated washed human platelets. by Greengard (1984)
  172. 10.1182/blood.V71.5.1268.bloodjournal7151268 / Blood / High-molecular weight kininogen is present in cultured human endothelial cells: Localization, isolation, and characterization. by van Iwaarden (1988)
  173. 10.1111/j.1365-2141.1984.tb03955.x / Br J Haematol / Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. by Kerbiriou-Nabias (1984)
  174. 10.1182/blood.V79.3.754.754 / Blood / Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. by Figueroa (1992)
  175. 10.1083/jcb.109.1.377 / J Cell Biol / High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. by Gustafson (1989)
  176. 10.1016/S0021-9258(19)88630-1 / J Biol Chem / Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. by Berrettini (1992)
  177. 10.1073/pnas.78.7.4046 / Proc Natl Acad Sci USA / On the attribution and additivity of binding energies. by Jencks (1981)
  178. 10.1016/S0006-291X(89)80178-0 / Biochem Biophys Res Commun / Conformation of high molecular weight kininogen: Effects of kallikrein and factor XIa cleavage. by Villanueva (1989)
  179. 10.1073/pnas.80.12.3734 / Proc Natl Acad Sci USA / Permanent cell lines expressing human factor VIII-related antigen established by hybridization. by Edgell (1983)
  180. 10.1074/jbc.271.22.13040 / J Biol Chem / Isolation and characterization of the kininogen-binding protein p33 from endothelial cells: Identity with the gC1q receptor. by Herwald (1996)
  181. 10.1084/jem.179.6.1809 / J Exp Med / Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular “heads” of C1q. by Ghebrehiwet (1994)
  182. 10.1073/pnas.93.16.8552 / Proc Natl Acad Sci USA / Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular “heads” of C1q (gC1qR). by Joseph (1996)
  183. {'key': '2019111912390634900_B183'}
  184. 10.1016/S0021-9258(19)50297-6 / J Biol Chem / Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. by Reddigari (1993)
  185. {'key': '2019111912390634900_B185'}
  186. 10.1126/science.273.5281.1551 / Science / Regulation of integrin function by the urokinase receptor. by Wei (1996)
  187. {'key': '2019111912390634900_B186a'}
  188. {'key': '2019111912390634900_B187'}
  189. 10.1242/jcs.108.3.1071 / J Cell Sci / A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surface of hepatocytes, HepG2 cells, and breast carcinoma cell line. by Hembrough (1995)
  190. 10.1074/jbc.271.41.25684 / J Biol Chem / Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. by Hembrough (1996)
  191. 10.1182/blood.V80.8.1980.1980 / Blood / Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. by Nishikawa (1992)
  192. 10.1172/JCI111361 / J Clin Invest / Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. by Sinha (1984)
  193. 10.1182/blood.V68.1.225.bloodjournal681225 / Blood / Functional characterization of platelet-bound factor XIa: Retention of factor XIa activity on the platelet surface. by Walsh (1986)
  194. 10.1055/s-0038-1642441 / Thromb Haemost / Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: A mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. by Loza (1994)
  195. 10.1084/jem.135.1.81 / J Exp Med / A prealbumin activator of prekallikrein II. Appearance of chemotactic activity for human neutrophils by the conversion of prekallikrein to kallikrein. by Kaplan (1972)
  196. 10.1172/JCI110557 / J Clin Invest / Purified human plasma kallikrein aggregates human blood neutrophils. by Schapira (1982)
  197. 10.1172/JCI111126 / J Clin Invest / Human plasma kallikrein releases neutrophil elastase during blood coagulation. by Wachtfogel (1983)
  198. 10.1055/s-0038-1647130 / Thromb Haemost / Purified human plasma kallikrein does not stimulate but primes neutrophils for superoxide production. by Zimmerli (1989)
  199. 10.1172/JCI110482 / J Clin Invest / Leukocyte elastase release during blood coagulation: A potential mechanism for activation of the alternative fibrinolytic pathway. by Plow (1982)
  200. 10.1093/ajcp/79.4.405 / Am J Clin Pathol / The skin window as a monitor of leukocytic functions in contact activation factor deficiencies in man. by Rebuck (1983)
  201. 10.1182/blood.V65.2.311.bloodjournal652311 / Blood / Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties. by Colman (1985)
  202. 10.1182/blood.V67.6.1731.bloodjournal6761731 / Blood / Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. by Wachtfogel (1986)
  203. 10.1172/JCI113765 / J Clin Invest / Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor. by Chien (1988)
  204. {'key': '2019111912390634900_B203'}
  205. 10.1073/pnas.89.24.11969 / Proc Natl Acad Sci USA / Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). by Toossi (1992)
  206. 10.1016/0005-2760(83)90261-8 / Biochim Biophys Acta / Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists. by Crutchley (1983)
  207. 10.1016/0049-3848(80)90201-7 / Thromb Res / Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein. by Hong (1980)
  208. 10.1002/jcp.1041430104 / J Cell Physiol / Bradykinin induces superoxide anion release from human endothelial cells. by Holland (1990)
  209. 10.1182/blood.V66.4.835.bloodjournal664835 / Blood / Tissue plasminogen activator release in vivo in response to vasoactive agents. by Smith (1983)
  210. 10.1055/s-0038-1656000 / Thromb Haemost / Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. by Brown (1997)
  211. 10.1038/327524a0 / Nature / Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. by Palmer (1987)
  212. 10.1172/JCI116907 / J Clin Invest / Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. by Nakashima (1993)
  213. 10.1111/j.1476-5381.1990.tb12105.x / Br J Pharmacol / Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. by Boulanger (1990)
  214. {'key': '2019111912390634900_B213', 'first-page': '581', 'article-title': 'Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells.', 'volume': '252', 'author': 'Schini', 'year': '1990', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells. by Schini (1990)
  215. 10.1016/0014-5793(90)81445-T / FEBS Lett / Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. by Busse (1990)
  216. 10.1172/JCI117005 / J Clin Invest / Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. by Imai (1994)
  217. {'key': '2019111912390634900_B216'}
  218. {'key': '2019111912390634900_B217'}
  219. 10.1073/pnas.88.17.7724 / Proc Natl Acad Sci USA / Expression cloning of a rat B2 bradykinin receptor. by McEachern (1991)
  220. 10.1016/S0021-9258(17)31844-6 / J Biol Chem / Expression cloning of a human B1 bradykinin receptor. by Menke (1994)
  221. 10.1161/01.HYP.25.3.453 / Hypertension / Early blockade of bradykinin B2-receptors alters the adult cardiovascular phenotype in rats. by Madeddu (1995)
  222. 10.1093/cvr/28.2.166 / Cardiovasc Res / Endothelial protection by converting enzyme inhibitors. by Wiemer (1994)
  223. {'key': '2019111912390634900_B222', 'first-page': '183', 'article-title': 'Cardioprotection by angiotensin converting enzyme inhibitors-the experimental evidence.', 'volume': '28', 'author': 'Parratt', 'year': '1994', 'journal-title': 'Circ Res'} / Circ Res / Cardioprotection by angiotensin converting enzyme inhibitors-the experimental evidence. by Parratt (1994)
  224. 10.1016/0022-2828(92)91103-C / Mol Cell Cardiol / ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. by Linz (1992)
  225. {'key': '2019111912390634900_B224'}
  226. 10.1161/01.HYP.23.4.411 / Hypertension / Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. by Gohlke (1994)
  227. 10.1161/01.HYP.25.2.162 / Hypertension / Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin. by O'Sullivan (1995)
  228. 10.1152/jappl.1994.77.6.2675 / J Appl Physiol / Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. by Siebeck (1994)
  229. 10.1161/01.HYP.23.2.236 / Hypertension / Human tissue kallikrein induces hypotension in transgenic mice. by Wang (1994)
  230. 10.1074/jbc.270.1.451 / J Biol Chem / Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. by Ma (1995)
  231. 10.1042/bj2390325 / Biochem J / Identification of a new tissue-kallikrein-binding protein. by Chao (1986)
  232. 10.1016/S0021-9258(17)46236-3 / J Biol Chem / Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. by Chao (1990)
  233. 10.1016/S0021-9258(18)35690-4 / J Biol Chem / Kallistatin: A novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. by Zhou (1992)
  234. 10.1172/JCI117847 / J Clin Invest / Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats [see comments]. by Wang (1995)
  235. 10.1161/01.HYP.25.4.715 / Hypertension / Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. by Xiong (1995)
  236. {'key': '2019111912390634900_B235', 'first-page': '232', 'article-title': 'Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.', 'volume': '100', 'author': 'Puri', 'year': '1987', 'journal-title': 'Trans Assoc Am Phys'} / Trans Assoc Am Phys / Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen. by Puri (1987)
  237. 10.1182/blood.V60.3.731.bloodjournal603731 / Blood / Effects of tertiary amine local anesthetics on von Willebrand factor-dependent platelet function: Alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s). by Coller (1982)
  238. 10.1016/0006-291X(89)90775-4 / Biochem Biophys Res Commun / Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine. by Puri (1989)
  239. {'key': '2019111912390634900_B238', 'first-page': '32', 'article-title': 'Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.', 'volume': '7', 'author': 'Matsueda', 'year': '1994', 'journal-title': 'Pept Res'} / Pept Res / Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation. by Matsueda (1994)
  240. 10.1172/JCI108841 / J Clin Invest / Interrelations of platelet aggregation and secretion. by Charo (1977)
  241. 10.1016/0049-3848(92)90010-8 / Thromb Res / PPACK-thrombin is a noncompetitive inhibitor of alpha-thrombin binding to human platelets. by Schmaier (1992)
  242. 10.1182/blood.V90.4.1508.1508_1508_1515 / Blood / Human kininogens regulate thrombin binding to platelets through the GPIb-IX complex. by Bradford (1997)
  243. 10.1016/0006-2952(93)90127-I / Biochem Pharmacol / Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo. by Majima (1993)
  244. 10.1254/jjp.60.111 / Jpn J Pharmacol / A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma. by Shima (1992)
  245. 10.1055/s-0038-1654415 / Thromb Diath Haemorrh / Role of the contact factor (Hageman factor) in fibrinolysis. by Niewiarowski (1959)
  246. 10.1016/0006-291X(69)90278-2 / Biochem Biophys Res Commun / Activation of plasminogen by human plasma kallikrein. by Colman (1969)
  247. 10.1016/S0021-9258(17)40034-2 / J Biol Chem / Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman-factor-dependent fibrinolysis. by Mandle (1977)
  248. 10.1172/JCI109113 / J Clin Invest / The activation of plasminogen by Hageman FXII (factor XII) and Hageman factor fragments. by Goldsmith (1978)
  249. 10.1182/blood.V54.4.850.bloodjournal544850 / Blood / Hageman-factor-dependent fibrinolysis: Generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. by Mandle (1979)
  250. 10.1016/0014-5793(93)80537-5 / FEBS Lett / Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis. by Gurewich (1993)
  251. 10.1182/blood.V90.2.690 / Blood / High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation. by Lin (1997)
  252. 10.1074/jbc.270.29.17375 / J Biol Chem / Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. by Higazi (1995)
  253. 10.1055/s-0038-1655060 / Thromb Diath Haemorrh / Possible involvement of fibrinogen and proteolysis in surface activation: A study with the recording ellipsometer. by Vroman (1967)
  254. 10.1016/0049-3848(84)90154-3 / Thromb Res / The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. by Schmaier (1984)
  255. 10.1182/blood.V71.4.932.bloodjournal714932 / Blood / Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: Role of the contact and fibrinolytic systems. by Brash (1988)
  256. 10.1016/0162-3109(96)00003-3 / Immunopharmacology / Neutrophil adhesion on surfaces preadsorbed with high molecular weight kininogen under well-defined flow conditions. by Yung (1996)
  257. 10.1016/0002-9343(63)90162-1 / Am J Med / Biochemical abnormality in hereditary angioneurotic edema. by Donaldson (1963)
  258. 10.1084/jem.106.2.327 / J Exp Med / Some properties of an esterase derived from preparations of the first component of complement. by Ratnoff (1955)
  259. {'key': '2019111912390634900_B258'}
  260. 10.1056/NEJM198305053081802 / N Engl J Med / Prekallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. by Schapira (1983)
  261. {'key': '2019111912390634900_B260', 'first-page': '38', 'article-title': 'Generation of plasmin during acute attacks of hereditary angioedema.', 'volume': '121', 'author': 'Cugno', 'year': '1993', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Generation of plasmin during acute attacks of hereditary angioedema. by Cugno (1993)
  262. 10.1182/blood.V68.2.455.bloodjournal682455 / Blood / Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunblotting with monoclonal antibodies. by Berrettini (1986)
  263. 10.1016/0091-6749(83)90052-0 / J Allergy Clin Immunol / Kinin formation in hereditary angioedema plasma: Evidence aginst kinin derivation from C2 and in support of “spontaneous” formation of bradykinin. by Fields (1983)
  264. 10.1172/JCI103067 / J Clin Invest / Effect of glass upon the activation of various plasma clotting factors. by Rapaport (1955)
  265. 10.1055/s-0038-1649054 / Thromb Diath Haemorrh / Cold-promoted activation of factor VII. III. Relation to the kallikrein system. by Gjonnaess (1972)
  266. 10.1172/JCI109543 / J Clin Invest / Activation of human factor VII in plasma and in purified systems. by Seligsohn (1979)
  267. 10.1182/blood.V68.1.239.bloodjournal681239 / Blood / The effect of C1 inhibitor upon Hageman factor autoactivation. by Weiss (1986)
  268. 10.1093/infdis/151.6.1019 / J Infect Dis / Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. by Kalter (1985)
  269. 10.1056/NEJM198905043201809 / N Engl J Med / The role of plasma proteases in septic shock. by Colman (1989)
  270. {'key': '2019111912390634900_B269', 'first-page': '270', 'article-title': 'Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.', 'volume': '112', 'author': 'Carvalho', 'year': '1988', 'journal-title': 'J Lab Clin Med'} / J Lab Clin Med / Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. by Carvalho (1988)
  271. {'key': '2019111912390634900_B270', 'first-page': '325', 'article-title': 'The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease.', 'volume': '26', 'author': 'Mason', 'year': '1971', 'journal-title': 'Thromb Diath Haemorrh'} / Thromb Diath Haemorrh / The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. by Mason (1971)
  272. {'key': '2019111912390634900_B271', 'first-page': '539', 'article-title': 'Kinin activation in the blood of patients with sepsis.', 'volume': '143', 'author': "O'Donnell", 'year': '1976', 'journal-title': 'Surg Gynecol Obstet'} / Surg Gynecol Obstet / Kinin activation in the blood of patients with sepsis. by O'Donnell (1976)
  273. 10.1172/JCI108938 / J Clin Invest / Plasma kallikrein activation and inhibition during typhoid fever. by Colman (1978)
  274. {'key': '2019111912390634900_B273', 'first-page': '237', 'article-title': 'Prekallikrein activation in the adult respiratory distress syndrome.', 'volume': '21', 'author': 'Schapira', 'year': '1985', 'journal-title': 'Bull Eur Physiopathol Respir'} / Bull Eur Physiopathol Respir / Prekallikrein activation in the adult respiratory distress syndrome. by Schapira (1985)
  275. 10.1056/NEJM198804213181603 / N Engl J Med / A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. by Rao (1988)
  276. 10.1182/blood.V72.6.1841.1841 / Blood / Quantification of plasma factor XIIa-Cl(−)-inhibitor and kallikrein-Cl(−)-inhibitor complexes in sepsis. by Nuijens (1988)
  277. 10.1182/blood.V77.12.2660.2660 / Blood / Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. by Kaufman (1991)
  278. 10.1182/blood.V81.12.3313.3313 / Blood / Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. by DeLa (1993)
  279. {'key': '2019111912390634900_B278', 'first-page': '1', 'article-title': 'Activation of the contact system in lethal hypotensive bacteremia in a baboon model.', 'volume': '140', 'author': 'Pixley', 'year': '1992', 'journal-title': 'Am J Pathol'} / Am J Pathol / Activation of the contact system in lethal hypotensive bacteremia in a baboon model. by Pixley (1992)
  280. 10.1172/JCI116201 / J Clin Invest / The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. by Pixley (1993)
  281. 10.1111/j.1749-6632.1989.tb22493.x / Ann NY Acad Sci / Effect of heparin on the inhibition of the contact system enzymes. by Colman (1989)
  282. 10.1182/blood.V73.2.468.468 / Blood / Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass. by Wachtfogel (1989)
  283. 10.1016/S0022-5223(19)33735-3 / J Thorac Cardiovasc Surg / Aprotinin inhibits the contact, neutrophil and platelet activation systems during simulated extracorporeal perfusion. by Wachtfogel (1993)
  284. {'key': '2019111912390634900_B283'}
  285. {'key': '2019111912390634900_B284'}
  286. 10.1096/fasebj.9.5.7896018 / FASEB J / Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat. by DeLa (1995)
  287. 10.1053/gast.1996.v110.pm8613052 / Gastroenterology / Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. by Sartor (1996)
  288. 10.1007/BF02091530 / Dig Dis Sci / Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat. by Stadnicki (1996)
  289. 10.1182/blood.V87.6.2337.bloodjournal8762337 / Blood / Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. by Jansen (1996)
  290. 10.1097/00005792-198307000-00004 / Medicine (Baltimore) / Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases [Review]. by Goodnough (1983)
  291. 10.1016/0268-9499(87)90046-4 / Fibrinolysis / Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. by Mannhalter (1987)
  292. 10.1055/s-0038-1647467 / Thromb Haemost / Thromboembolism and bleeding tendency in congenital factor XII deficiency: A study on 74 subjects from 14 Swiss families. by Lammle (1991)
  293. 10.1055/s-0038-1656366 / Thromb Haemost / The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. by Halbmayer (1992)
  294. 10.1097/00001721-199210000-00006 / Blood Coagul Fibrinolysis / Factor XII clotting activity and antigen levels in patients with thromboembolic disease. by von Kanel (1992)
  295. 10.1111/j.1749-6632.1992.tb51648.x / Ann NY Acad Sci / Evidence for a role of factor XII-dependent fibrinolysis in cardiovascular diseases. by Jespersen (1992)
  296. 10.1016/0735-1097(91)90879-E / J Am Coll Cardiol / Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: A randomized placebo-controlled study. by Munkvad (1991)
Dates
Type When
Created 5 years, 10 months ago (Oct. 12, 2019, 5:35 p.m.)
Deposited 1 year, 11 months ago (Sept. 21, 2023, 11:45 a.m.)
Indexed 2 weeks, 1 day ago (Aug. 7, 2025, 5:04 p.m.)
Issued 27 years, 9 months ago (Nov. 15, 1997)
Published 27 years, 9 months ago (Nov. 15, 1997)
Published Print 27 years, 9 months ago (Nov. 15, 1997)
Funders 0

None

@article{Colman_1997, title={Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes}, volume={90}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v90.10.3819}, DOI={10.1182/blood.v90.10.3819}, number={10}, journal={Blood}, publisher={American Society of Hematology}, author={Colman, Robert W. and Schmaier, Alvin H.}, year={1997}, month=nov, pages={3819–3843} }